Project Details
Description
A Phase I Trial to Determine Safety and Tolerability of Ex Vivo Expanded Human Myeloid Progenitor Cells (CLT-008) Infused 24 Hours Post-Transplant to Support Allogeneic Umbilical Cord Blood Transplantation for Hematologic Malignancies
| Status | Finished |
|---|---|
| Effective start/end date | 12/1/08 → 12/31/14 |
Funding
- CELLERANT THERAPEUTICS, INC.
- U.S. DEPARTMENT OF HEALTH & HUMAN SVCS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.